KY OxyContin Appeal
OxyContin Maker Urges Judge to Keep Its Marketing Techniques Secret
June 27, 2017
Purdue Pharma, the large pharmaceutical corporation that makes the controversial opioid painkiller OxyContin, has just petitioned the Kentucky Court of Appeals to overturn a lower court ruling that the company release the secret records of its marketing strategy for the drug.
Kentucky’s Pike Circuit Court ruled in May 2016 that Purdue must unseal records pertaining to its marketing plan for OxyContin. The drug is an opioid, and, like other drugs of its kind, has been implicated in the tens of thousands of injuries and deaths that have come to be known as the nationwide “opioid epidemic.”
Kentucky Court of Appeals Judge Glenn Acree said that he intended to rule on Purdue’s appeal within 45 days.
The records in question are part of a lawsuit brought by the state of Kentucky against Purdue Pharma. The suit alleges that the company’s marketing of OxyContin was at least partly responsible for the injuries, deaths, and crimes that are characteristic of the abuse of opioid painkillers.
Purdue argues that the lower court judge did not have the legal authority to order the documents unsealed.
OxyContin’s marketing strategy did not adequately inform doctors or patients of the dangers of addiction to the drug. In 2007, Purdue pleaded guilty to a federal criminal charge of deliberately mislabeling OxyContin in order to mislead doctors and patients. The company paid more than $600 million in fines.
The documents in question include notes from sales meetings, internal emails pertaining to marketing strategies, results from clinical trials, and other types of communications.
At TheLawFirm.com, we believe that Big Pharma will always ignore individuals’ health in the name of profit. We also believe that if you or a loved one has been adversely affected by mislabeled or misprescribed opioid medications, you may be entitled to significant financial compensation.
Contact TheLawFirm.com to learn how we can help you.
Talk with aN Attorney now!
VA urged to address risks of opioids for veterans
More states added to lawsuit against opioid makers
Drugstores try to block cherokee opioid lawsuit
Insys settles Illinois opioid lawsuit
Insys Blue Cross and Blue Shield lawsuit
Fentanyl likely cause of boys death
FDA urged to block opioid suppliers
Opioid Atty Gen
FDA urged to remove opioids from market
FDA urges Opana to be pulled from the shelves
Oxycontin secret marketing
FDA approved drugs
FDA denies use of blue dye in opioids
FDA faults Canadian drugmaker for opioid abuse
Opioid lawsuit settlement
Opioids causing National epidemic
Opioid privileges revoked
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!